🔗 Share this article

Texas Attorney General Paxton is taking legal action against the manufacturers of acetaminophen, claiming the corporations concealed potential risks that the pain reliever created to children's cognitive development.

The court filing arrives a month after Former President Trump advocated an unverified association between consuming acetaminophen - referred to as paracetamol - during pregnancy and autism in young ones.

The attorney general is filing suit against J&J, which formerly manufactured the drug, the sole analgesic recommended for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "misled consumers by profiting off of suffering and promoting medication ignoring the risks."

The manufacturer states there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening numerous people to increase profits," the attorney general, a Republican, stated.

The company commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its website, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between using acetaminophen and autism."

Groups acting on behalf of physicians and healthcare providers concur.

ACOG has declared acetaminophen - the key substance in acetaminophen - is one of the few options for women during pregnancy to address pain and fever, which can pose major wellness concerns if left untreated.

"In more than two decades of research on the utilization of paracetamol in gestation, not a single reputable study has conclusively proven that the use of acetaminophen in any stage of pregnancy causes neurodevelopmental disorders in children," the association stated.

This legal action mentions latest statements from the Trump administration in claiming the medication is potentially dangerous.

Recently, Trump generated worry from health experts when he told pregnant women to "struggle intensely" not to take acetaminophen when unwell.

The FDA then issued a notice that doctors should contemplate reducing the usage of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in minors has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in April to initiate "comprehensive study program" that would determine the source of autism spectrum disorder in a limited time.

But experts advised that finding a sole reason of autism - considered by experts to be the result of a complex mix of inherited and environmental factors - would prove challenging.

Autism is a form of enduring cognitive variation and impairment that affects how people encounter and interact with the environment, and is recognized using doctors' observations.

In his legal document, the attorney general - who supports Trump who is campaigning for the Senate - claims the manufacturer and J&J "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the corporations "remove any promotional materials" that claims Tylenol is reliable for expectant mothers.

This legal action parallels the concerns of a assembly of parents of children with autism and ADHD who sued the producers of Tylenol in recently.

The court threw out the legal action, saying studies from the plaintiffs' authorities was not conclusive.